Status:
RECRUITING
Efficacy of Topical Versus Intravenous Tranexamic Acid in Controlling Blood Loss
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
To Calculate Total Blood Loss Immediately Postoperative
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Total laryngectomy with bilateral block neck dissection is considered one of the major head and neck surgeries. Intraoperative bleeding is considered a risk factor for this operation specially that th...
Detailed Description
45 patients undergoing total laryngectomy operation will be enrolled in this study. The patients will be divided into 3 equal groups, 15 patients in each group. Group (A), tranexamic acid will be give...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Patients of either sex, aged between 18-70 years old, ASA physical status I, II undergoing total laryngectomy
- Exclusion Criteria:
- Patients with coagulopathy, a history of thromboembolism or a history of tranexamic acid allergy or complication will be excluded.
Exclusion
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06188052
Start Date
August 1 2023
End Date
January 31 2024
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University hospitals
Cairo, Egypt, 11559